Industrials · Services-Management Services · NYSE · CIK 1628908 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $3.30Day −11.76%Mkt cap $371M1Y −64.9%Off 52W high −67.9%Vol (1Y) 78.3%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,801 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest13.1% of sh out |
| Days to cover6.6d |
| 13F net flow (QoQ)−4.35% |
| Top-10 13F concentration59.7% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.89B |
| Earnings (TTM)-$496.5M |
| ROE−75.5% |
| Net margin−28.5% |
| ROIC−24.7% |
| Debt / equity2.34× |
| Sales growth 3Y11.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−17.5% |
| 1Y−64.9% |
| 3Y−89.1% |
| 5Y−85.1% |
| 10Y−86.0% |
| Since incept. (ann.)−14.5% |
Total return through 2026-07-29 · series begins 2015-06-05. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)78.3% |
| Ann. volatility (3Y)70.4% |
| Sharpe (1Y)−0.99 |
| Sharpe (3Y)−0.68 |
| Max drawdown (1Y)−78.4% |
| Max drawdown (3Y)−93.8% |
| Beta (3Y vs SPY)2.05 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 10.9M | $25M | 9.68% | +5.4% |
| CADIAN CAPITAL MANAGEMENT, LP | 10.8M | $25M | 9.61% | −2.4% |
| MORGAN STANLEY | 9.1M | $21M | 8.07% | −2.1% |
| UBS Group AG | 8.2M | $19M | 7.25% | +33.4% |
| Rubicon Founders LLC | 5.8M | $13M | 5.17% | +0.0% |
| Engaged Capital LLC | 5.6M | $13M | 4.95% | +0.0% |
| D. E. Shaw & Co., Inc. | 5.4M | $12M | 4.83% | +3.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.9M | $11M | 4.33% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.24 | — | $496.2M | +2.6% |
| 2025-12-31 | 2026-02-24 | −$3.84 | — | $468.7M | −27.5% |
| 2025-09-30 | 2025-11-06 | −$0.24 | — | $479.5M | −22.8% |
| 2025-06-30 | 2025-08-07 | −$0.44 | — | $444.3M | −31.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 50% · Evolent Health Services 50%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
